nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Quinine—ABCB1—colon cancer	0.00708	0.439	CrCbGaD
Quinidine barbiturate—Quinidine—ABCB1—colon cancer	0.00622	0.386	CrCbGaD
Quinidine barbiturate—Phenobarbital—ABCB1—colon cancer	0.00282	0.175	CrCbGaD
Quinidine barbiturate—Irritability—Capecitabine—colon cancer	0.0026	0.00264	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Capecitabine—colon cancer	0.00259	0.00263	CcSEcCtD
Quinidine barbiturate—Mood swings—Capecitabine—colon cancer	0.00258	0.00262	CcSEcCtD
Quinidine barbiturate—Ataxia—Capecitabine—colon cancer	0.00256	0.0026	CcSEcCtD
Quinidine barbiturate—Coma—Methotrexate—colon cancer	0.00255	0.0026	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Irinotecan—colon cancer	0.00254	0.00259	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Irinotecan—colon cancer	0.00254	0.00258	CcSEcCtD
Quinidine barbiturate—Mental disorder—Vincristine—colon cancer	0.00253	0.00258	CcSEcCtD
Quinidine barbiturate—Chills—Irinotecan—colon cancer	0.00253	0.00257	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Methotrexate—colon cancer	0.00253	0.00257	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Capecitabine—colon cancer	0.00252	0.00256	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Capecitabine—colon cancer	0.00249	0.00253	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Capecitabine—colon cancer	0.00249	0.00253	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Methotrexate—colon cancer	0.00249	0.00253	CcSEcCtD
Quinidine barbiturate—Breast disorder—Capecitabine—colon cancer	0.00246	0.0025	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00245	0.00249	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Capecitabine—colon cancer	0.0024	0.00244	CcSEcCtD
Quinidine barbiturate—Asthma—Capecitabine—colon cancer	0.00235	0.00239	CcSEcCtD
Quinidine barbiturate—Erythema—Fluorouracil—colon cancer	0.00235	0.00239	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Capecitabine—colon cancer	0.00232	0.00235	CcSEcCtD
Quinidine barbiturate—Agitation—Vincristine—colon cancer	0.00231	0.00235	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Methotrexate—colon cancer	0.00231	0.00235	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Capecitabine—colon cancer	0.00229	0.00233	CcSEcCtD
Quinidine barbiturate—Vertigo—Vincristine—colon cancer	0.00226	0.0023	CcSEcCtD
Quinidine barbiturate—Leukopenia—Vincristine—colon cancer	0.00225	0.00229	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Capecitabine—colon cancer	0.00224	0.00227	CcSEcCtD
Quinidine barbiturate—Vision blurred—Fluorouracil—colon cancer	0.00221	0.00225	CcSEcCtD
Quinidine barbiturate—Vertigo—Irinotecan—colon cancer	0.0022	0.00224	CcSEcCtD
Quinidine barbiturate—Neutropenia—Capecitabine—colon cancer	0.0022	0.00224	CcSEcCtD
Quinidine barbiturate—Syncope—Irinotecan—colon cancer	0.0022	0.00223	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Methotrexate—colon cancer	0.0022	0.00223	CcSEcCtD
Quinidine barbiturate—Leukopenia—Irinotecan—colon cancer	0.00219	0.00223	CcSEcCtD
Quinidine barbiturate—Convulsion—Vincristine—colon cancer	0.00218	0.00222	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Irinotecan—colon cancer	0.00215	0.00219	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Methotrexate—colon cancer	0.00215	0.00218	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Capecitabine—colon cancer	0.00215	0.00218	CcSEcCtD
Quinidine barbiturate—Myalgia—Vincristine—colon cancer	0.00214	0.00218	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Methotrexate—colon cancer	0.00214	0.00218	CcSEcCtD
Quinidine barbiturate—Leukopenia—Fluorouracil—colon cancer	0.0021	0.00214	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00208	0.00212	CcSEcCtD
Quinidine barbiturate—Lethargy—Methotrexate—colon cancer	0.00207	0.0021	CcSEcCtD
Quinidine barbiturate—Renal failure—Capecitabine—colon cancer	0.00206	0.0021	CcSEcCtD
Quinidine barbiturate—Oedema—Vincristine—colon cancer	0.00205	0.00209	CcSEcCtD
Quinidine barbiturate—Jaundice—Capecitabine—colon cancer	0.00205	0.00208	CcSEcCtD
Quinidine barbiturate—Convulsion—Fluorouracil—colon cancer	0.00203	0.00207	CcSEcCtD
Quinidine barbiturate—Confusional state—Irinotecan—colon cancer	0.00202	0.00205	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Vincristine—colon cancer	0.00201	0.00205	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Vincristine—colon cancer	0.00201	0.00204	CcSEcCtD
Quinidine barbiturate—Oedema—Irinotecan—colon cancer	0.002	0.00203	CcSEcCtD
Quinidine barbiturate—Myalgia—Fluorouracil—colon cancer	0.002	0.00203	CcSEcCtD
Quinidine barbiturate—Chest pain—Fluorouracil—colon cancer	0.002	0.00203	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Vincristine—colon cancer	0.00199	0.00202	CcSEcCtD
Quinidine barbiturate—Shock—Irinotecan—colon cancer	0.00197	0.002	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Irinotecan—colon cancer	0.00196	0.00199	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Capecitabine—colon cancer	0.00196	0.00199	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Irinotecan—colon cancer	0.00196	0.00199	CcSEcCtD
Quinidine barbiturate—Anorexia—Vincristine—colon cancer	0.00196	0.00199	CcSEcCtD
Quinidine barbiturate—Irritability—Methotrexate—colon cancer	0.00194	0.00197	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Irinotecan—colon cancer	0.00193	0.00197	CcSEcCtD
Quinidine barbiturate—Confusional state—Fluorouracil—colon cancer	0.00193	0.00196	CcSEcCtD
Quinidine barbiturate—Mood swings—Methotrexate—colon cancer	0.00192	0.00195	CcSEcCtD
Quinidine barbiturate—Hypotension—Vincristine—colon cancer	0.00192	0.00195	CcSEcCtD
Quinidine barbiturate—Bradycardia—Capecitabine—colon cancer	0.00192	0.00195	CcSEcCtD
Quinidine barbiturate—Oedema—Fluorouracil—colon cancer	0.00192	0.00195	CcSEcCtD
Quinidine barbiturate—Anorexia—Irinotecan—colon cancer	0.00191	0.00194	CcSEcCtD
Quinidine barbiturate—Ataxia—Methotrexate—colon cancer	0.00191	0.00194	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Capecitabine—colon cancer	0.00189	0.00193	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Capecitabine—colon cancer	0.00188	0.00192	CcSEcCtD
Quinidine barbiturate—Hepatitis—Capecitabine—colon cancer	0.00188	0.00192	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Fluorouracil—colon cancer	0.00188	0.00191	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Fluorouracil—colon cancer	0.00188	0.00191	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Methotrexate—colon cancer	0.00187	0.0019	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Vincristine—colon cancer	0.00187	0.0019	CcSEcCtD
Quinidine barbiturate—Tachycardia—Fluorouracil—colon cancer	0.00187	0.0019	CcSEcCtD
Quinidine barbiturate—Hypotension—Irinotecan—colon cancer	0.00187	0.0019	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Capecitabine—colon cancer	0.00186	0.00189	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Capecitabine—colon cancer	0.00185	0.00188	CcSEcCtD
Quinidine barbiturate—Breast disorder—Methotrexate—colon cancer	0.00183	0.00186	CcSEcCtD
Quinidine barbiturate—Anorexia—Fluorouracil—colon cancer	0.00183	0.00186	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00183	0.00186	CcSEcCtD
Quinidine barbiturate—Visual impairment—Capecitabine—colon cancer	0.00182	0.00185	CcSEcCtD
Quinidine barbiturate—Hypotension—Fluorouracil—colon cancer	0.00179	0.00182	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Vincristine—colon cancer	0.00179	0.00182	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Irinotecan—colon cancer	0.00178	0.00181	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Capecitabine—colon cancer	0.00178	0.00181	CcSEcCtD
Quinidine barbiturate—Somnolence—Irinotecan—colon cancer	0.00178	0.00181	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Vincristine—colon cancer	0.00177	0.0018	CcSEcCtD
Quinidine barbiturate—Eye disorder—Capecitabine—colon cancer	0.00176	0.00179	CcSEcCtD
Quinidine barbiturate—Tinnitus—Capecitabine—colon cancer	0.00176	0.00179	CcSEcCtD
Quinidine barbiturate—Pain—Vincristine—colon cancer	0.00176	0.00179	CcSEcCtD
Quinidine barbiturate—Constipation—Vincristine—colon cancer	0.00176	0.00179	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—colon cancer	0.00175	0.00178	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Capecitabine—colon cancer	0.00175	0.00178	CcSEcCtD
Quinidine barbiturate—Flushing—Capecitabine—colon cancer	0.00175	0.00178	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00175	0.00177	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Irinotecan—colon cancer	0.00174	0.00177	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Irinotecan—colon cancer	0.00173	0.00176	CcSEcCtD
Quinidine barbiturate—Pain—Irinotecan—colon cancer	0.00171	0.00174	CcSEcCtD
Quinidine barbiturate—Constipation—Irinotecan—colon cancer	0.00171	0.00174	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Fluorouracil—colon cancer	0.00171	0.00174	CcSEcCtD
Quinidine barbiturate—Somnolence—Fluorouracil—colon cancer	0.0017	0.00173	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Capecitabine—colon cancer	0.0017	0.00173	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Capecitabine—colon cancer	0.0017	0.00173	CcSEcCtD
Quinidine barbiturate—Chills—Capecitabine—colon cancer	0.00169	0.00172	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Vincristine—colon cancer	0.00168	0.00171	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Fluorouracil—colon cancer	0.00167	0.00169	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—colon cancer	0.00166	0.00169	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00165	0.00168	CcSEcCtD
Quinidine barbiturate—Mental disorder—Capecitabine—colon cancer	0.00165	0.00168	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Irinotecan—colon cancer	0.00165	0.00168	CcSEcCtD
Quinidine barbiturate—Erythema—Capecitabine—colon cancer	0.00164	0.00167	CcSEcCtD
Quinidine barbiturate—Malnutrition—Capecitabine—colon cancer	0.00164	0.00167	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—colon cancer	0.00164	0.00167	CcSEcCtD
Quinidine barbiturate—Pain—Fluorouracil—colon cancer	0.00164	0.00167	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Vincristine—colon cancer	0.00162	0.00165	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Vincristine—colon cancer	0.00162	0.00165	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—colon cancer	0.0016	0.00163	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Irinotecan—colon cancer	0.00158	0.00161	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Irinotecan—colon cancer	0.00158	0.00161	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Fluorouracil—colon cancer	0.00158	0.00161	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—colon cancer	0.00156	0.00159	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00155	0.00158	CcSEcCtD
Quinidine barbiturate—Vision blurred—Capecitabine—colon cancer	0.00155	0.00157	CcSEcCtD
Quinidine barbiturate—Tremor—Capecitabine—colon cancer	0.00154	0.00156	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—colon cancer	0.00154	0.00156	CcSEcCtD
Quinidine barbiturate—Urticaria—Fluorouracil—colon cancer	0.00152	0.00155	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Fluorouracil—colon cancer	0.00151	0.00154	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vincristine—colon cancer	0.00151	0.00154	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—colon cancer	0.0015	0.00152	CcSEcCtD
Quinidine barbiturate—Vertigo—Capecitabine—colon cancer	0.00147	0.0015	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Irinotecan—colon cancer	0.00147	0.0015	CcSEcCtD
Quinidine barbiturate—Asthenia—Vincristine—colon cancer	0.00147	0.0015	CcSEcCtD
Quinidine barbiturate—Syncope—Capecitabine—colon cancer	0.00147	0.0015	CcSEcCtD
Quinidine barbiturate—Leukopenia—Capecitabine—colon cancer	0.00147	0.00149	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—colon cancer	0.00146	0.00148	CcSEcCtD
Quinidine barbiturate—Palpitations—Capecitabine—colon cancer	0.00145	0.00147	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Capecitabine—colon cancer	0.00144	0.00147	CcSEcCtD
Quinidine barbiturate—Asthenia—Irinotecan—colon cancer	0.00144	0.00146	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Fluorouracil—colon cancer	0.00141	0.00144	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—colon cancer	0.00141	0.00143	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vincristine—colon cancer	0.00141	0.00143	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—colon cancer	0.0014	0.00143	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—colon cancer	0.0014	0.00143	CcSEcCtD
Quinidine barbiturate—Chest pain—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Quinidine barbiturate—Myalgia—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Quinidine barbiturate—Arthralgia—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Quinidine barbiturate—Anxiety—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—colon cancer	0.00139	0.00141	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—colon cancer	0.00138	0.0014	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Irinotecan—colon cancer	0.00137	0.00139	CcSEcCtD
Quinidine barbiturate—Dizziness—Vincristine—colon cancer	0.00136	0.00138	CcSEcCtD
Quinidine barbiturate—Pruritus—Fluorouracil—colon cancer	0.00136	0.00138	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—colon cancer	0.00135	0.00137	CcSEcCtD
Quinidine barbiturate—Confusional state—Capecitabine—colon cancer	0.00135	0.00137	CcSEcCtD
Quinidine barbiturate—Oedema—Capecitabine—colon cancer	0.00134	0.00136	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—colon cancer	0.00133	0.00135	CcSEcCtD
Quinidine barbiturate—Dizziness—Irinotecan—colon cancer	0.00132	0.00134	CcSEcCtD
Quinidine barbiturate—Shock—Capecitabine—colon cancer	0.00132	0.00134	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Capecitabine—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Fluorouracil—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Capecitabine—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Tachycardia—Capecitabine—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Vomiting—Vincristine—colon cancer	0.00131	0.00133	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Quinidine barbiturate—Skin disorder—Capecitabine—colon cancer	0.0013	0.00132	CcSEcCtD
Quinidine barbiturate—Rash—Vincristine—colon cancer	0.0013	0.00132	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Capecitabine—colon cancer	0.00129	0.00132	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vincristine—colon cancer	0.00129	0.00132	CcSEcCtD
Quinidine barbiturate—Headache—Vincristine—colon cancer	0.00129	0.00131	CcSEcCtD
Quinidine barbiturate—Anorexia—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Quinidine barbiturate—Vomiting—Irinotecan—colon cancer	0.00127	0.00129	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—colon cancer	0.00127	0.00129	CcSEcCtD
Quinidine barbiturate—Dizziness—Fluorouracil—colon cancer	0.00127	0.00129	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—colon cancer	0.00126	0.00129	CcSEcCtD
Quinidine barbiturate—Rash—Irinotecan—colon cancer	0.00126	0.00128	CcSEcCtD
Quinidine barbiturate—Dermatitis—Irinotecan—colon cancer	0.00126	0.00128	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—colon cancer	0.00126	0.00128	CcSEcCtD
Quinidine barbiturate—Headache—Irinotecan—colon cancer	0.00125	0.00127	CcSEcCtD
Quinidine barbiturate—Hypotension—Capecitabine—colon cancer	0.00125	0.00127	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—colon cancer	0.00123	0.00125	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—colon cancer	0.00122	0.00124	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—colon cancer	0.00122	0.00124	CcSEcCtD
Quinidine barbiturate—Nausea—Vincristine—colon cancer	0.00122	0.00124	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Quinidine barbiturate—Vomiting—Fluorouracil—colon cancer	0.00122	0.00124	CcSEcCtD
Quinidine barbiturate—Rash—Fluorouracil—colon cancer	0.00121	0.00123	CcSEcCtD
Quinidine barbiturate—Dermatitis—Fluorouracil—colon cancer	0.00121	0.00123	CcSEcCtD
Quinidine barbiturate—Headache—Fluorouracil—colon cancer	0.0012	0.00122	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Capecitabine—colon cancer	0.00119	0.00121	CcSEcCtD
Quinidine barbiturate—Nausea—Irinotecan—colon cancer	0.00119	0.00121	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Quinidine barbiturate—Pain—Capecitabine—colon cancer	0.00115	0.00116	CcSEcCtD
Quinidine barbiturate—Constipation—Capecitabine—colon cancer	0.00115	0.00116	CcSEcCtD
Quinidine barbiturate—Nausea—Fluorouracil—colon cancer	0.00114	0.00116	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Capecitabine—colon cancer	0.0011	0.00112	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—colon cancer	0.00109	0.00111	CcSEcCtD
Quinidine barbiturate—Urticaria—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—colon cancer	0.00106	0.00108	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—colon cancer	0.00101	0.00102	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Capecitabine—colon cancer	0.000987	0.001	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—colon cancer	0.000978	0.000994	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—colon cancer	0.000976	0.000992	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—colon cancer	0.000968	0.000984	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—colon cancer	0.000964	0.00098	CcSEcCtD
Quinidine barbiturate—Asthenia—Capecitabine—colon cancer	0.000961	0.000977	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—colon cancer	0.00095	0.000966	CcSEcCtD
Quinidine barbiturate—Pruritus—Capecitabine—colon cancer	0.000947	0.000963	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—colon cancer	0.000932	0.000947	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Capecitabine—colon cancer	0.000916	0.000931	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000908	0.000923	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—colon cancer	0.000889	0.000903	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—colon cancer	0.000886	0.000901	CcSEcCtD
Quinidine barbiturate—Dizziness—Capecitabine—colon cancer	0.000886	0.0009	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—colon cancer	0.000867	0.000881	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000861	0.000875	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—colon cancer	0.000853	0.000866	CcSEcCtD
Quinidine barbiturate—Vomiting—Capecitabine—colon cancer	0.000851	0.000865	CcSEcCtD
Quinidine barbiturate—Rash—Capecitabine—colon cancer	0.000844	0.000858	CcSEcCtD
Quinidine barbiturate—Dermatitis—Capecitabine—colon cancer	0.000844	0.000857	CcSEcCtD
Quinidine barbiturate—Headache—Capecitabine—colon cancer	0.000839	0.000853	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—colon cancer	0.000822	0.000835	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—colon cancer	0.000815	0.000829	CcSEcCtD
Quinidine barbiturate—Nausea—Capecitabine—colon cancer	0.000795	0.000808	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—colon cancer	0.000792	0.000805	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—colon cancer	0.000788	0.000801	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—colon cancer	0.000788	0.000801	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—colon cancer	0.000734	0.000747	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—colon cancer	0.000715	0.000727	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—colon cancer	0.000705	0.000717	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—colon cancer	0.000682	0.000693	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—colon cancer	0.000659	0.00067	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—colon cancer	0.000634	0.000644	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—colon cancer	0.000629	0.000639	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—colon cancer	0.000628	0.000638	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—colon cancer	0.000625	0.000635	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—colon cancer	0.000592	0.000602	CcSEcCtD
